Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/306% below fair value
$70.96−1.28 (-1.77%)
Close on Nov 19, 2026Market cap $225.92MP/E 21.6Yield –
Utah Medical Products free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Utah Medical Products's free cash flow for the twelve months ending Jun 30, 2026 was $11.45M. For fiscal 2025 it was $14.32M, down 1.9% from the year before. Over ten years it grew 0.5% a year on average. The highest annual figure on record is $21.64M in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.32M | -1.9% |
| FY2024 | Dec 31, 2024 | $14.60M | -32.5% |
| FY2023 | Dec 31, 2023 | $21.64M | +6.4% |
| FY2022 | Dec 31, 2022 | $20.34M | -1.5% |
| FY2021 | Dec 31, 2021 | $20.65M | +7.1% |
| FY2020 | Dec 31, 2020 | $19.28M | +16.7% |
| FY2019 | Dec 31, 2019 | $16.52M | +0.5% |
| FY2018 | Dec 31, 2018 | $16.43M | +7.3% |
| FY2017 | Dec 31, 2017 | $15.31M | +36.3% |
| FY2016 | Dec 31, 2016 | $11.24M | -17.5% |
| FY2015 | Dec 31, 2015 | $13.63M | -4.6% |
| FY2014 | Dec 31, 2014 | $14.28M | +19.3% |
| FY2013 | Dec 31, 2013 | $11.97M | -10.1% |
| FY2012 | Dec 31, 2012 | $13.31M | +19.7% |
| FY2011 | Dec 31, 2011 | $11.12M | +97.7% |
| FY2010 | Dec 31, 2010 | $5.63M | -16.8% |
| FY2009 | Dec 31, 2009 | $6.76M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.25M | -55.7% |
| Q1 FY2026 | Mar 31, 2026 | $2.98M | -30.4% |
| Q4 FY2025 | Dec 31, 2025 | $3.37M | -35.7% |
| Q3 FY2025 | Sep 30, 2025 | $3.85M | -22.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.82M | -38.6% |
| Q1 FY2025 | Mar 31, 2025 | $4.28M | -37.7% |
| Q4 FY2023 | Dec 31, 2023 | $5.24M | -7.1% |
| Q3 FY2023 | Sep 30, 2023 | $4.94M | -6.3% |
| Q2 FY2023 | Jun 30, 2023 | $4.59M | -0.6% |
| Q1 FY2023 | Mar 31, 2023 | $6.87M | +42.9% |
| Q4 FY2022 | Dec 31, 2022 | $5.64M | +19.2% |
| Q3 FY2022 | Sep 30, 2022 | $5.27M | -10.9% |
| Q2 FY2022 | Jun 30, 2022 | $4.62M | +3.1% |
| Q1 FY2022 | Mar 31, 2022 | $4.81M | -12.9% |
| Q4 FY2021 | Dec 31, 2021 | $4.73M | -17.3% |
| Q3 FY2021 | Sep 30, 2021 | $5.91M | +20.4% |
| Q2 FY2021 | Jun 30, 2021 | $4.48M | +31.0% |
| Q1 FY2021 | Mar 31, 2021 | $5.52M | +5.8% |
| Q4 FY2020 | Dec 31, 2020 | $5.72M | +6.9% |
| Q3 FY2020 | Sep 30, 2020 | $4.91M | -21.4% |
| Q2 FY2020 | Jun 30, 2020 | $3.42M | +118.5% |
| Q1 FY2020 | Mar 31, 2020 | $5.22M | +55.9% |
| Q4 FY2019 | Dec 31, 2019 | $5.35M | +23.5% |
| Q3 FY2019 | Sep 30, 2019 | $6.25M | +37.4% |
| Q2 FY2019 | Jun 30, 2019 | $1.57M | -60.4% |
| Q1 FY2019 | Mar 31, 2019 | $3.35M | -6.8% |
| Q4 FY2018 | Dec 31, 2018 | $4.34M | +37.1% |
| Q3 FY2018 | Sep 30, 2018 | $4.55M | +0.6% |
| Q2 FY2018 | Jun 30, 2018 | $3.95M | +16.7% |
| Q1 FY2018 | Mar 31, 2018 | $3.59M | -15.3% |
| Q4 FY2017 | Dec 31, 2017 | $3.16M | +861.1% |
| Q3 FY2017 | Sep 30, 2017 | $4.52M | +39.9% |
| Q2 FY2017 | Jun 30, 2017 | $3.39M | -5.2% |
| Q1 FY2017 | Mar 31, 2017 | $4.24M | +3.4% |
| Q4 FY2016 | Dec 31, 2016 | $329.00K | -91.5% |
| Q3 FY2016 | Sep 30, 2016 | $3.23M | – |
| Q2 FY2016 | Jun 30, 2016 | $3.57M | – |
| Q1 FY2016 | Mar 31, 2016 | $4.10M | – |
| Q4 FY2015 | Dec 31, 2015 | $3.88M | – |
See a number that looks wrong?